Universitätsklinikum Schleswig-Holstein (UKSH)

Lenalidomide, adriamycin, dexamethasone (RAD) for induction followed by stem-cell transplant in newly diagnosed myeloma (2017) Knop S, Langer C, Engelhardt M, Muegge LO, Reichle A, Rösler W, Bassermann F, et al. Journal article Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture (2017) Hutchinson JA, Riquelme P, Bach C, Kekarainen T, Faendrich F, Geissler EK, Ahrens N Journal article Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article En-bloc resection of bladder tumours (ERBT): current and future perspectives (2017) Struck JP, Kramer MW, Merseburger AS, Hartmann A, Herrmann TRW Journal article Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis (2017) Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, Maldonado SG, et al. Journal article Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study (2017) Petrova E, Rueckert F, Zach S, Shen Y, Weitz J, Grützmann R, Wittel UA, et al. Journal article Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology (2017) Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, et al. Journal article Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling (2017) Dand N, Mucha S, Tsoi LC, Mahil SK, Stuart PE, Arnold A, Baurecht H, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial (2017) Einsele H, Engelhardt M, Tapprich C, Mueller J, Liebisch P, Langer C, Kropff M, et al. Journal article